Redox Stock

Data integrator between hospitals and digital health apps

Sign up today and learn more about Redox Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Redox Stock

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better.

Funding History

November 2014$470K
October 2015$3.5M
January 2017$9.0M
April 2017$1.0M
August 2018$3.0M
April 2019$33.0M


Software Developer

Andy Kitson


Niko Skievaski


Liam Donohue


James Lloyd

Marketing and Developer Advocate

George Mclaughlin

Software Developer

Christopher "TC" Tobin-Campbell


Nijay Patel

Director of Implementation

Devin Soelberg

HL7 Whisperer

Nick Hatt


Luke Bonney

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: